for more information about stanelco click on the links.

driver's research page link
http://www.moneyam.com/InvestorsRoom/posts.php?tid=7681#lastread
website link
http://www.stanelco.co.uk/index.htm

Hi All,

=========================================

The National Provisioner

Corporate Spotlight

Introducing Greenseal

New packaging technology incorporates RF technology.
http://www.nationalprovisioner.com/content.php?s=NP/2005/08&p=39

==========================================

Cheers,
PM

Paul - you do manage to find some obscure publicity.

Good find - well done

Baza

Baz
It looks old to me.

Any publicity is good publicity

Baza

Driver Hi,

If you click on the home page, it's the August issue of the magazine, probably still being read in various companies, probably in their reception areas too ....

Cheers,
PM

Hi All,

Tree shakes and a half today, you could buy for as low as 18.25, and sell 10 minutes later for 19p .... are the MM's expecting news too ?

Cheers,
PM

Has Stanelco got a Trademark??

http://www.greenseal.org/index.html

Not sure Niels. That website though-Organisation is Green Seal - two separate words - not Greenseal like SEO's product. Dunno if that makes a difference coming to copywrite. I'm sure someone here know about this......

Picked this up from another board:-

"I believe that the vegetarian capsules are a huge market. As I understand it (from information manufacturers have given me) the problem previously has been that any company wishing to offer gelatine free capsules has had to produce their own, which involved a huge outlay and also they had to make sure they didn't infringe the patents of those who did offer them. This will now open the market to all those companies unable to offer vegetarian versions of their vitamins etc. I can only imagine that almost every manufacturer will adopt these capsules, in preference to gelatine, if the costs are similar and the changeover easy. "

Baza

Niels - in answer to your question do Stanelco have a Trade Mark for Green Seal - in the UK they have an application only - details below.

There is a registration in the name of Food Investments Limited which may cause problems - details below.

In the U.S. they do not appear to even have an application. Probably because of the 'Certification' mark registered there - details below. They will need to be authorised to use the Certification Mark (probably no problem there) but ANYONE will be able to use the mark once authorised. This means Stanelco WILL NOT have exclusive use of the word GREENSEAL in the U.S. Not a great choice of Trade Mark IMO. It would have been better to have a Mark that identifies it as a Stanelco product. GREENSEAL does not.

===========


DETAILS FOR COMMUNITY TRADE MARK E4351169

Mark text:
GREENSEAL

UK case status: New Application


Original language: English
Second language: French


Classes: 07, 20


Relevant dates
Filing date: 16.03.2005


List of goods or services
Class 07:
Dielectric welding equipment for packaging products.
Class 20:
Plastic trays for packaging food.

Names and addresses
Applicant: Stanelco RF Technologies Ltd
Starpol Technology Centre North Road Marchwood Industrial Park Marchwood, Southampton, United Kingdom, SO40 4BL


Representative: Peter Turquand Mansfield
329 Harwell, Didcot, Oxfordshire, United Kingdom, OX11 0QJ


===========

Trade Mark Details as at 13.09.2005
CASE DETAILS FOR TRADE MARK 2008234


Mark Text :

GREEN SEAL


Status: Registered

Class: 30

Relevant Dates

Filing Date: 19.01.1995
Registration Date: 31.05.1996
Next Renewal Date: 19.01.2015


Publication in Trade Marks Journal

Journal Page Publication Date
First Advert 6096 8501 11.10.1995
Registration 6135 24.07.1996
Renewal 6564 07.01.2005


List of goods and/or services

Class 30:
Flour; bread, bread products; confectionery; bakery products; farinaceous
foodstuffs; cereals, cereal preparations; but not including cake mixes and/or
dessert mixes.


Names and Addresses

Proprietor: Food Investments Limited
Weston Centre,Bowater House,68 Knightsbridge,London,SW1X 7LQ

Residence Country: United Kingdom
Customer's Ref: PDH/CLC
ADP Number: 0706923001


===========

=============



U.S. TRADE MARKS




Word Mark GREEN SEAL CERTIFIED
Goods and Services IC A . US A . G & S: office machines and supplies, lamps, ballasts and lighting equipment, petroleum products, household appliances, food packaging
Mark Drawing Code (3) DESIGN PLUS WORDS, LETTERS, AND/OR NUMBERS
Design Search Code 241715 260108 260121
Serial Number 78496847
Filing Date October 8, 2004
Current Filing Basis 1B
Original Filing Basis 1B
Owner (APPLICANT) Green Seal, Inc. CORPORATION DELAWARE Suite 827 1001 Connecticut Avenue, NW Washington, DC D.C. 20036
Attorney of Record Anne H. Peck
Prior Registrations 1863375
Disclaimer NO CLAIM IS MADE TO THE EXCLUSIVE RIGHT TO USE "CERTIFIED" APART FROM THE MARK AS SHOWN
Description of Mark The mark consists of the words GREEN SEAL CERTIFIED and design of a check and circle.
Type of Mark CERTIFICATION MARK
Register PRINCIPAL
Other Data The certification mark, as it will be used by persons authorized by Applicant, certifies that the goods are environmentally preferable.
Live/Dead Indicator LIVE

Hi All,

Cardinal Health Capsules ....

http://www.cardinal.com/pts/vitamins/hardcap/CH-PTS-OT-Hardshell-Sellsheets.pdf

Cheers,
PM

pick of the week
Medi-Caps Ltd.(MEDCAP)

By Sirshendu Basu
Medicaps Ltd (MCL), is a over Rs. 200 million ISO 9002 certified manufacturer of Hard Gelatine Capsules with an annual capacity of 3500 million capsules making it Indias Second largest manufacture of hard gelatin capsules. Good business outlook coupled with attractive valuations make MCL an attractive investment idea.

Background

Medi-Caps Ltd, incorporated in 1986, flagship company of Medi-Caps Group, is one of the largest manufacturer of empty hard gelatin capsules in terms of manufacturing capacity as well as market capitalization in India. Clear focus, excellent infrastructure, a powerful quality policy and a well-defined management information system have helped the company to achieve consistent growth. Today, MCL has an annual capacity of 3500 million capsules and is backed by the services of more than 300 employees. MCL is also supported by a distribution channel spread all over India and has an excellent modern factory housed in almost 80,000 sq. ft of constructed space, set amidst a sprawling lawn area of 3.14 hectares

Financials:
The Operating Income of the company saw a decline from Rs. 228.37 million to Rs. 205.31 million. Net Profit of the company also saw a marginal decline of 7.58% in FY2005 to Rs. 38.14 million (Rs. 41.27 million). However during the quarter ended June 2005, the operating income rose by 31.64 % to Rs.44.10 million (Rs. 33.5 million) and the operating profit was up to Rs. 6.8 million (Rs.0.6 million) Q-O-Q.


http://content.icicidirect.com/PickofWeek.asp?id=223

Erm,

I think you posted that one in the wrong thread, Paul.

This is the Stanelco thread, not Medicaps!

bos re your "i believe the yanks are organising a charity concert along the lines of live aid to help with the aid effort", I heard the Animals are reforming to perform their old standard "There Was A House In New Orleans"!

if it's bad taste you want . . . .

sd

Overview
We are one of Indias largest exporters of branded generic pharmaceuticals products. We
manufacture pharmaceuticals formulations in various dosage forms, including capsules, tablets,
liquid injectibles and we are one of the worlds top five manufacturers of soft gel capsules. We
also have the only globally dedicated soft gel facility for hormones. In addition, we undertake
contract research and the manufacturing of speciality chemicals for various multinational
companies. We have a major presence in various developing countries such as Africa, Latin
America and Asia as well as in developed markets such as the US, Canada and parts of Europe.
We are one of the largest Indian suppliers of institutionally funded aid projects and we are an
approved supplier to the World Bank, the African Development Bank and UNICEF, amongst
others.
We have 11 manufacturing plants spread across the US, Brazil, Mexico and India. This
broad manufacturing network facilitates partnering with global organisations ranging from
UNICEF and WHO-Global Drug Facility to European and American pharmaceutical
multinationals and also private labellers and distribution chains. We have product registrations
in over 37 countries around the world and we have earned ISO 9001, ISO 14001 and GMP
accreditations. We employ approximately 1,300 people across the globe. We also have a
marketing presence in over 50 countries.
Our consolidated total revenues for fiscal 2002, 2003 and 2004 was Rs.2,781.49 million
(US$64.28 million), Rs.4,276.73 million (US$98.84 million) and Rs.4,624.50 million (US$106.88
million), respectively.


Overview
According to data from IMS Health Incorporated, or IMS, the world pharmaceutical market
size was estimated to be US$466 billion in 2003, based on audited retail sales of prescription
Pharmaceuticals and some over-the-counter products in more than 60 countries. IMS similarly
expects the global pharmaceutical market to show significant growth, despite continued
government pressure on pricing, measures for cost control and a number of widely-used drugs
going off patent, which usually results in a drop in price for those products. IMS estimates
average annual global sales to grow 18.5 per cent. and the global pharmaceutical market to
expand to US$561 billion by 2005. According to IMS, combined sales in the 13 leading markets
increased 8 per cent. to US$309.78 billion in 12 months up to November 2003. IMS predicts a
compound annual growth rate of 9.7 per cent. to US$688 billion for the global market over the
2002-2007 period. The United States market representing nearly half of all global sales is
expected to drive most of the world wide growth over this period with a CAGR of 12.5 per cent.
North America, the worlds largest pharmaceutical market, accounted for US$172 billion of
pharmaceutical sales, or 54 per cent. of sales of the 13 key global markets. Over 70 per cent. of
the growth in the global pharmaceutical industry in 2003 came from the United States. For a
further description of the United States pharmaceutical industry, see The United States
pharmaceutical market.



http://www.stridesarco.com/pdfdocs/FCCB_Offering.pdf

Obo Hi,

Very funny ;)

Cheers,
PM

pm1
This is all a bit over whelming for my small brain?

I think basically - there is a massive potential market for our capsules

Baza

baz
Thanks baz I needed some help.

The 2006-2011 World Outlook for Unfilled Gelatin Capsules, Gelatin Sheets for Theatrical Use, and Photographic-Grade and Technical-Grade Gelatin

http://www.marketresearch.com/product/display.asp?productid=1111950&g=1

Check the price, !!!!